<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0301-696X</journal-id>
<journal-title><![CDATA[Revista de sanidad militar]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. sanid. mil.]]></abbrev-journal-title>
<issn>0301-696X</issn>
<publisher>
<publisher-name><![CDATA[Secretaría de la Defensa Nacional, Dirección General de Sanidad]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0301-696X2022000300003</article-id>
<article-id pub-id-type="doi">10.56443/rsm.v76i3.254</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Expresión de miRNAs en orina como herramienta de diagnóstico y pronóstico en cáncer de próstata]]></article-title>
<article-title xml:lang="en"><![CDATA[Expression of urine miRNAs as a diagnostic and prognostic tool in prostate cancer]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rodríguez-Báez]]></surname>
<given-names><![CDATA[Álvaro]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Comoto-Santacruz]]></surname>
<given-names><![CDATA[David Alberto]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Saldaña-Rivera]]></surname>
<given-names><![CDATA[Elsa]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rodríguez-Ayala]]></surname>
<given-names><![CDATA[Ernesto]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Escuela Militar de Graduados de Sanidad  ]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>México</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad Anáhuac  ]]></institution>
<addr-line><![CDATA[ Estado de México]]></addr-line>
<country>Mexico</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>09</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>09</month>
<year>2022</year>
</pub-date>
<volume>76</volume>
<numero>3</numero>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S0301-696X2022000300003&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S0301-696X2022000300003&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S0301-696X2022000300003&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Introducción:  El cáncer de próstata es la principal causa de muerte por cáncer en México, el diagnóstico inicial se hace mediante la medición del antígeno prostático específico y el tacto rectal de la próstata. Sin embargo, hay limitaciones que incluye la capacidad para distinguir con precisión los pacientes con y sin cáncer y aquellos que presentan una forma agresiva de la enfermedad. Los microRNAs se encuentran alterados en el tejido prostático canceroso, incluyendo aquellos casos fármaco resistentes. Los miRNAs son reguladores de la expresión génica y se encuentran involucrados en diversos procesos patológicos. Se ha demostrado que estas moléculas son detectables en orina.  Objetivo:  Esta revisión presenta la información sobre cuáles son los miRNAs reportados en orina como posibles marcadores para el diagnóstico, pronóstico y respuesta a la terapia en cáncer de próstata.  Resultados: De la búsqueda realizada en la bibliografía, se encontraron 13 miRNAs en los diferentes estudios, miR-19a, miR-19b, miR-21, miR-148a, miR-375, miR-125b-5p, miR-151-5p, miR-141, miR-200b, miR-221, miR-107, miR-26b-5p, miR-205-5p. Teniendo algunos miRNAs como miR-375, miR-21, miR-141 encontrados en varios estudios.  Limitaciones del estudio o implicaciones: Se puede concluir es factible obtener la medición por métodos no invasivos de miRNAs en pacientes con cáncer de próstata.  Originalidad o valor:  Es un estudio de revisión respecto a los miRNAs obtenidos en muestras de orina en pacientes con cáncer de próstata.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Introduction: Prostate cancer is the leading cause of cancer death in Mexico, the initial diagnosis is made by measuring the Prostate Specific Antigen and the digital rectal examination of the prostate. However, there are limitations including the ability to accurately distinguish patients with and without cancer and those with an aggressive form of the disease. MicroRNAs are altered in cancerous prostate tissue, including drug-resistant cases. MiRNAs are regulators of gene expression and are involved in various pathological processes. These molecules have been shown to be detectable in urine.  Objective:  This review presents the information on which are the miRNAs reported in urine as possible markers for the diagnosis, prognosis and response to therapy in prostate cancer. Results: From the literature search, 13 miRNAs were found in the different studies, miR-19a, miR-19b, miR-21, miR-148a, miR-375, miR-125b-5p, miR-151-5p , miR-141, miR-200b, miR-221, miR-107, miR-26b-5p, miR-205-5p. Having some miRNAs like miR-375, miR-21, miR-141 found in various studies.  Limitations of the study or implications: It can be concluded that it is feasible to obtain the measurement of miRNAs by non-invasive methods in patients with prostate cancer.  Originality or value: It is a review study regarding miRNAs obtained in urine samples in patients with prostate cancer.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[miRNA]]></kwd>
<kwd lng="en"><![CDATA[gene expression]]></kwd>
<kwd lng="en"><![CDATA[urine]]></kwd>
<kwd lng="en"><![CDATA[prostate cancer]]></kwd>
<kwd lng="es"><![CDATA[miRNA]]></kwd>
<kwd lng="es"><![CDATA[expresión génica]]></kwd>
<kwd lng="es"><![CDATA[orina]]></kwd>
<kwd lng="es"><![CDATA[cáncer de próstata]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ferlay]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Colombet]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Soerjomataram]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Parkin]]></surname>
<given-names><![CDATA[DM]]></given-names>
</name>
<name>
<surname><![CDATA[Piñeros]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Znaor]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cancer statistics for the year 2020: An overview]]></article-title>
<source><![CDATA[International Journal of Cancer]]></source>
<year>2021</year>
<volume>149</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>778-89</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="book">
<collab>Dirección General Adjunta de Comunicación</collab>
<source><![CDATA[A propósito del Día Mundial contra el cáncer (4 de febrero)]]></source>
<year>2021</year>
<page-range>1-11</page-range><publisher-loc><![CDATA[México ]]></publisher-loc>
<publisher-name><![CDATA[Instituto Nacional de Estadística y Geografía]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lima]]></surname>
<given-names><![CDATA[AR]]></given-names>
</name>
<name>
<surname><![CDATA[Bastos]]></surname>
<given-names><![CDATA[M de L]]></given-names>
</name>
<name>
<surname><![CDATA[Carvalho]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Guedes de Pinho]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Biomarker Discovery in Human Prostate Cancer: an Update in Metabolomics Studies]]></article-title>
<source><![CDATA[Translational Oncology]]></source>
<year>2016</year>
<volume>9</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>357-70</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Duffy]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[PSA in screening for prostate cancer: more good than harm or more harm than good?]]></article-title>
<source><![CDATA[Adv Clin Chem]]></source>
<year>2014</year>
<volume>66</volume>
<page-range>1-23</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lekchnov]]></surname>
<given-names><![CDATA[EA]]></given-names>
</name>
<name>
<surname><![CDATA[Amelina]]></surname>
<given-names><![CDATA[EV]]></given-names>
</name>
<name>
<surname><![CDATA[Bryzgunova]]></surname>
<given-names><![CDATA[OE]]></given-names>
</name>
<name>
<surname><![CDATA[Zaporozhchenko]]></surname>
<given-names><![CDATA[IA]]></given-names>
</name>
<name>
<surname><![CDATA[Konoshenko]]></surname>
<given-names><![CDATA[MYu]]></given-names>
</name>
<name>
<surname><![CDATA[Yarmoschuk]]></surname>
<given-names><![CDATA[SV]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Searching for the Novel Specific Predictors of Prostate Cancer in Urine: The Analysis of 84 miRNA Expression]]></article-title>
<source><![CDATA[Int J Mol Sci]]></source>
<year>2018</year>
<volume>19</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>4088</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[López Chente-Casado]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Soto-Guzmán]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Candia-Plata]]></surname>
<given-names><![CDATA[M del C]]></given-names>
</name>
<name>
<surname><![CDATA[Arriaga-Aguilar]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Camacho-Villa]]></surname>
<given-names><![CDATA[Alma Y]]></given-names>
</name>
<name>
<surname><![CDATA[García-Vásquez]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Valor clínico del tacto rectal y antígeno prostático específico en la detección oportuna del cáncer de próstata en Hermosillo, Sonora]]></article-title>
<source><![CDATA[Rev Mex Urol]]></source>
<year>2013</year>
<volume>73</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>299-306</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kuligowska]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Barish]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Fenlon]]></surname>
<given-names><![CDATA[HM]]></given-names>
</name>
<name>
<surname><![CDATA[Blake]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Predictors of Prostate Carcinoma: Accuracy of Gray-Scale and Color Doppler US and Serum Markers]]></article-title>
<source><![CDATA[Radiology]]></source>
<year>2001</year>
<volume>220</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>757-64</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Foj]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Ferrer]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Serra]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Arévalo]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Gavagnach]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Giménez]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Exosomal and Non-Exosomal Urinary miRNAs in Prostate Cancer Detection and Prognosis]]></article-title>
<source><![CDATA[Prostate]]></source>
<year>2017</year>
<volume>77</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>573-83</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Acosta]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Varela]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Mesa]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[López]]></surname>
<given-names><![CDATA[MLS]]></given-names>
</name>
<name>
<surname><![CDATA[Cómbita]]></surname>
<given-names><![CDATA[AL]]></given-names>
</name>
<name>
<surname><![CDATA[Sanabria-Salas]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Biomarcadores de pronóstico en pacientes con cáncer de próstata localizado]]></article-title>
<source><![CDATA[Revista Colombiana de Cancerología]]></source>
<year>2017</year>
<volume>21</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>113-25</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Saini]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[PSA and beyond: alternative prostate cancer biomarkers]]></article-title>
<source><![CDATA[Cell Oncol]]></source>
<year>2016</year>
<volume>39</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>97-106</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Prensner]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
<name>
<surname><![CDATA[Rubin]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Wei]]></surname>
<given-names><![CDATA[JT]]></given-names>
</name>
<name>
<surname><![CDATA[Chinnaiyan]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Beyond PSA: the next generation of prostate cancer biomarkers]]></article-title>
<source><![CDATA[Sci Transl Med]]></source>
<year>2012</year>
<volume>4</volume>
<numero>127</numero>
<issue>127</issue>
<page-range>127rv3</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Xu]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Qi]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Duan]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Xie]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Ren]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[MicroRNAs: potential biomarkers for disease diagnosis]]></article-title>
<source><![CDATA[Biomed Mater Eng]]></source>
<year>2014</year>
<volume>24</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>3917-25</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Endzeli&#326;&#353;]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Melne]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Kalni&#326;a]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Lietuvietis]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Rieksti&#326;a]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
<name>
<surname><![CDATA[Llorente]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diagnostic, prognostic and predictive value of cell-free miRNAs in prostate cancer: a systematic review]]></article-title>
<source><![CDATA[Molecular Cancer]]></source>
<year>2016</year>
<volume>15</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>41</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Balacescu]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Petrut]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Tudoran]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Feflea]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Balacescu]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Anghel]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Urinary microRNAs for prostate cancer diagnosis, prognosis, and treatment response: are we there yet?]]></article-title>
<source><![CDATA[WIREs RNA]]></source>
<year>2017</year>
<volume>8</volume>
<numero>6</numero>
<issue>6</issue>
</nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rodríguez Báez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Expresión de microARNs circulantes como opción para la detección de cáncer de próstata]]></article-title>
<source><![CDATA[Revista Mexicana de Urología]]></source>
<year>2017</year>
<volume>77</volume>
<numero>3</numero>
<issue>3</issue>
</nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Aakula]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Kohonen]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Leivonen]]></surname>
<given-names><![CDATA[S-K]]></given-names>
</name>
<name>
<surname><![CDATA[Mäkelä]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Hintsanen]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Mpindi]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Systematic Identification of MicroRNAs That Impact on Proliferation of Prostate Cancer Cells and Display Changed Expression in Tumor Tissue]]></article-title>
<source><![CDATA[European Urology]]></source>
<year>2016</year>
<volume>69</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>1120-8</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Stuopelyt&#279;]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Dani&#363;nait&#279;]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Jankevi&#269;ius]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Jarmalait&#279;]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Detection of miRNAs in urine of prostate cancer patients]]></article-title>
<source><![CDATA[Medicina]]></source>
<year>2016</year>
<volume>52</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>116-24</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Stuopelyte]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Daniunaite]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Bakavicius]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Lazutka]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
<name>
<surname><![CDATA[Jankevicius]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Jarmalaite]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The utility of urine-circulating miRNAs for detection of prostate cancer]]></article-title>
<source><![CDATA[Br J Cancer]]></source>
<year>2016</year>
<volume>115</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>707-15</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fredsøe]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Rasmussen]]></surname>
<given-names><![CDATA[AKI]]></given-names>
</name>
<name>
<surname><![CDATA[Thomsen]]></surname>
<given-names><![CDATA[AR]]></given-names>
</name>
<name>
<surname><![CDATA[Mouritzen]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Høyer]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Borre]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diagnostic and Prognostic MicroRNA Biomarkers for Prostate Cancer in Cell-free Urine]]></article-title>
<source><![CDATA[European Urology Focus]]></source>
<year>2018</year>
<volume>4</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>825-33</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wu]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Ni]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Beretov]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Cozzi]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Willcox]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Wasinger]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Urinary biomarkers in prostate cancer detection and monitoring progression]]></article-title>
<source><![CDATA[Crit Rev Oncol Hematol]]></source>
<year>2017</year>
<volume>118</volume>
<page-range>15-26</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ghorbanmehr]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Gharbi]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Korsching]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Tavallaei]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Einollahi]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Mowla]]></surname>
<given-names><![CDATA[SJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[miR-21-5p, miR-141-3p, and miR-205-5p levels in urine-promising biomarkers for the identification of prostate and bladder cancer]]></article-title>
<source><![CDATA[Prostate]]></source>
<year>2019</year>
<volume>79</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>88-95</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Szczyrba]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Löprich]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Wach]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Jung]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Unteregger]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Barth]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The MicroRNA Profile of Prostate Carcinoma Obtained by Deep Sequencing]]></article-title>
<source><![CDATA[Molecular Cancer Research]]></source>
<year>2010</year>
<volume>8</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>529-38</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hessvik]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Sandvig]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Llorente]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Exosomal miRNAs as Biomarkers for Prostate Cancer]]></article-title>
<source><![CDATA[Frontiers in Genetics]]></source>
<year>2013</year>
<volume>4</volume>
</nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ambs]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Prueitt]]></surname>
<given-names><![CDATA[RL]]></given-names>
</name>
<name>
<surname><![CDATA[Yi]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Hudson]]></surname>
<given-names><![CDATA[RS]]></given-names>
</name>
<name>
<surname><![CDATA[Howe]]></surname>
<given-names><![CDATA[TM]]></given-names>
</name>
<name>
<surname><![CDATA[Petrocca]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer]]></article-title>
<source><![CDATA[Cancer Res]]></source>
<year>2008</year>
<volume>68</volume>
<numero>15</numero>
<issue>15</issue>
<page-range>6162-70</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ahumada-Tamayo]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Saavedra-Briones]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Cantellano-Orozco]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Salido-Guadarrama]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez-Dorantes]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Urdiales-Ortiz]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Determinación de microRNA en orina para la detección de cáncer de próstata en pacientes mexicanos en el Hospital General Dr. Manuel Gea González]]></article-title>
<source><![CDATA[Rev Mex Urol]]></source>
<year>2011</year>
<volume>71</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>213-7</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zhu]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Wu]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Wu]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Nie]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Sheng]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Mo]]></surname>
<given-names><![CDATA[Y-Y]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[MicroRNA-21 targets tumor suppressor genes in invasion and metastasis]]></article-title>
<source><![CDATA[Cell Res]]></source>
<year>2008</year>
<volume>18</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>350-9</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lu]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Getz]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Miska]]></surname>
<given-names><![CDATA[EA]]></given-names>
</name>
<name>
<surname><![CDATA[Alvarez-Saavedra]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Lamb]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Peck]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[MicroRNA expression profiles classify human cancers]]></article-title>
<source><![CDATA[Nature]]></source>
<year>2005</year>
<volume>435</volume>
<numero>7043</numero>
<issue>7043</issue>
<page-range>834-8</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
